<DOC>
	<DOC>NCT00638391</DOC>
	<brief_summary>The purpose of this study is the initial/followed by 5 year adjuvant therapy with Anastrozole.</brief_summary>
	<brief_title>Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Postmenopausal women with early hormone receptor positive breast cancer/no metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Primary early MCa</keyword>
	<keyword>Arimidex</keyword>
</DOC>